When treating high grade gliomas abutting critical structures, how do you balance tumor dose with critical structure constraints?

The CTV should be shaved away from critical structures if they are likely not to be involved with tumor. That said, expansion with PTV can put dose back into these critical structures and it may be hard to achieve full coverage without exceeding critical structure constraints. Although for PTV, we a...